Burren Capital Advisors’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Burren Capital Advisors’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-31,381	Closed	-$819K	–	8
2019 Q1	$819K	Buy	+31,381	New	+$586K	5%	7

Burren Capital Advisors's CMTA Position: Q2 2019 in Review

Burren Capital Advisors sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 31,381 shares — an estimated $819K sold.

Burren Capital Advisors first reported a position in CMTA in Q1 2019 and held it in 1 quarter. The position peaked at $819K in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

Burren Capital Advisors reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
Burren Capital Advisors sold 31,381 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $819K.
Burren Capital Advisors first reported a position in Clementia Pharmaceuticals Inc. in Q1 2019 and held it in 1 quarter.
Burren Capital Advisors's Clementia Pharmaceuticals Inc. position peaked at $819K in Q1 2019.
0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Burren Capital Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.